Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cardiac Science Inc. DFIB (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Skywatcher who wrote (106)	11/12/2002 6:32:15 PM
From: Sergio H	Read Replies (1) \| Respond to of 174

Could be more defibrillator news from the FDA is coming up following today's development: < As of 11:38 a.m. EST Tuesday, November 12, 2002 In Today's Paper Columnists Portfolio Setup Center Discussions Site Map Help Contact Us Log Out Today In: BARRON'S Online @ Your Service Give a perfect gift The Online Journal OPEN: The Small Business NetworkSM. Go! Get 25 commission-free trades! Trade 5 Free @ Lind-Waldock. Click Now! IBM Fusion Webisodes The Smart Marketing Report from DoubleClick Transfer balances and save with a low 2.99% Intro APR* advertisement US FDA Approves First Defibrillator For At Home Use DOW JONES NEWSWIRES WASHINGTON (AP)--Federal health officials have approved the sale of the first defibrillator specifically for at-home use, a machine that promises to help people jump-start the heart of a collapsed loved one before paramedics ever arrive. The device is made by Netherlands-based Royal Philips Electronics (PHG). Every year, about 220,000 Americans collapse and die of cardiac arrest - without any warning, their hearts just suddenly stop beating. Cardio-Pulminary Resuscitation, or CPR, buys victims crucial time but only a defibrillator can restart a heart, with a jolt of electricity. Every minute spent waiting for paramedics to arrive with a defibrillator lowers the chance of survival by 10%. So portable versions of the electric shock paddles now are common in airports, shopping malls and even amusement parks. They are so easy to use that untrained passers-by have simply picked one up and saved lives. Doctors also occasionally prescribed those devices for heart disease patients to keep at home, in hopes that a relatives or visitor would revive them if they collapsed. But now the Food and Drug Administration has approved one manufacturer's version - a smaller and slightly less expensive model - for at-home use, a move that maker Philips Electronics and some heart experts hope will begin to make home defibrillators as common as smoke alarms and fire extinguishers. Sales of the HeartStart Home Defibrillator will begin within six weeks, a Philips spokesman said Tuesday. A doctor's prescription is required. The home defibrillator will cost $2,295, compared with about $3,500 for today's portable defibrillators. Philips initially will sell the home version directly to patients who have prescriptions via the Internet or telephone, but says CVS Corp. (CVS) pharmacies also will begin stocking the devices early next year. It is not yet clear whether insurance companies will pay for at-home defibrillators. But because most cases of cardiac arrest occur in the home, some heart experts have long called for at-home defibrillators. Others have cautioned that putting defibrillators in so many untrained hands could be risky, if a distraught spouse spends precious minutes hunting for the defibrillator instead of dialing 911. The FDA spent months working with Philips to rewrite instructions for the at-home defibrillator so that they are even easier to understand than models used in airports and shopping malls, said FDA cardiovascular chief Dan Schulz. The instructions are supposed to be understandable by a sixth-grader. Turn on the machine and it provides talking instructions, beginning with the reminder to take off the victim's shirt and then directions on how to place the shocking pads in the right spot on the chest. The device will detect if the person has a heartbeat -and will not shock if the patient doesn't need it, said FDA biomedical engineer Megan Moynahan.>